Investors who own more than 5% of a class must file a Schedule 13D or 13G. The latest filing for each security since 12/18/2024, newest first.
| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Edesa Biotech, Inc.
13D/A
EDSA · 27966L306
|
10.0% |
8/25/2026
Event 8/21/2026
|
|||
| Velan Capital Master Fund LP | 8.0% | ||||
| Velan Horizon Fund LP | 0.2% | ||||
| Velan Capital Opportunity Fund II LLC | 1.9% | ||||
| Velan Horizon GP LLC | 0.2% | ||||
| Velan Capital Holdings LLC | 9.8% | ||||
| Velan Capital Investment Management LP | 10.0% | ||||
| Velan Capital Management LLC | 10.0% | ||||
| Morgan Adam | 10.0% | ||||
| Venkataraman Balaji | 10.0% | ||||
|
Jasper Therapeutics, Inc.
13G
JSPR · 471871202
|
9.9% |
8/17/2026
Event 8/17/2026
|
|||
| Velan Capital Master Fund LP | 8.9% | ||||
| Velan Capital Holdings LLC | 8.9% | ||||
| Velan Horizon Fund LP | 0.2% | ||||
| Velan Horizon GP LLC | 0.2% | ||||
| Avego Healthcare Capital, L.P. | 0.7% | ||||
| Avego Healthcare Capital Holdings, LLC | 0.7% | ||||
| Avego Management LLC | 0.7% | ||||
| Velan Capital Investment Management LP | 9.9% | ||||
| Velan Capital Management LLC | 9.9% | ||||
| Morgan Adam | 9.9% | ||||
| Venkataraman Balaji | 9.9% | ||||
| Kapoor Vishal | 0.1% | ||||
|
InspireMD, Inc.
13G/A
NSPR · 45779A846
|
4.99% |
5/15/2026
Event 3/31/2026
|
|||
| Velan Capital Master Fund LP | 4.99% | ||||
| Velan Capital Holdings LLC | 4.99% | ||||
| Velan Capital Investment Management LP | 4.99% | ||||
| Velan Capital Management LLC | 4.99% | ||||
| Morgan Adam | 4.99% | ||||
| Venkataraman Balaji | 4.99% | ||||